{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:27:46Z","timestamp":1790180866234,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pnpbp.2021.110349","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T22:02:09Z","timestamp":1620856929000},"page":"110349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies"],"prefix":"10.1016","volume":"111","author":[{"given":"Helena","family":"Domin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2021.110349_bb0005","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00002508-199108000-00005","article-title":"Pain, analgesia, and stress: an integrated view","volume":"7","author":"Agnati","year":"1991","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/1381612826666200115101544","article-title":"Nose-to-brain delivery of natural compounds for the treatment of central nervous system disorders","volume":"26","author":"Bicker","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0015","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1124\/jpet.103.060459","article-title":"Characterization of N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl]acrylamide (JNJ-5207787), a small molecule antagonist of the neuropeptide Y Y2 receptor","volume":"308","author":"Bonaventure","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.npep.2013.10.012","article-title":"Neuropeptides in learning and memory","volume":"47","author":"Borb\u00e9ly","year":"2013","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tins.2015.08.012","article-title":"Neuropeptide Y: an anti-aging player?","volume":"38","author":"Botelho","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/mol.109.058677","article-title":"Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening","volume":"77","author":"Brothers","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0040","doi-asserted-by":"crossref","first-page":"36043","DOI":"10.1074\/jbc.M000626200","article-title":"The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats","volume":"275","author":"Cabrele","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0045","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1021\/bi0201421","article-title":"Ala31-Aib32: identification of the key motif for high affinity and selectivity of neuropeptide Y at the Y5-receptor","volume":"41","author":"Cabrele","year":"2002","journal-title":"Biochemistry."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/JMN:28:3:239","article-title":"Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice","volume":"28","author":"Carvajal","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0055","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1749-6632.1990.tb48932.x","article-title":"Modulation of synaptic transmission in hippocampus by neuropeptide Y: presynaptic actions","volume":"611","author":"Colmers","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0065","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI4188","article-title":"Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor","volume":"102","author":"Criscione","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000323468","article-title":"Neuroprotective effect of neuropeptide Y against \u03b2-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production","volume":"8","author":"Croce","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/cn200127e","article-title":"Neuropeptide Y protects rat cortical neurons against \u03b2-amyloid toxicity and re-establishes synthesis and release of nerve growth factor","volume":"3","author":"Croce","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","article-title":"NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?","volume":"376","author":"Croce","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2010.07.022","article-title":"Neuropeptide Y modifies the disease course in the R6\/2 transgenic model of Huntington\u2019s disease","volume":"226","author":"Decressac","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0095","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.neurobiolaging.2011.06.018","article-title":"Neuroprotection by neuropeptide Y in cell and animal models of Parkinson\u2019s disease","volume":"33","author":"Decressac","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijo.0801472","article-title":"Reduced food intake in response to CGP 71683A may be due to mechanisms other than NPY Y5 receptor blockade","volume":"25","author":"Della Zuana","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0105","first-page":"846","article-title":"Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures","volume":"58","author":"Domin","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcis.2014.09.053","article-title":"Neuropeptide Y and its C-terminal fragments acting on Y2 receptor: Raman and SERS spectroscopy studies","volume":"437","author":"Domin","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2016.12.040","article-title":"Neuropeptide Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats","volume":"344","author":"Domin","year":"2017","journal-title":"Neuroscience."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00213-016-4495-3","article-title":"Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence","volume":"234","author":"Domin","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0125","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/acschemneuro.9b00082","article-title":"Characterization of the brain penetrant neuropeptide Y Y2 receptor antagonist SF-11","volume":"10","author":"Domin","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0130","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(99)00650-0","article-title":"BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist","volume":"384","author":"Doods","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b2(1-40)) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0140","first-page":"7","article-title":"An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization","volume":"95","author":"Dumont","year":"2006","journal-title":"EXS."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1139\/y99-119","article-title":"Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5)","volume":"78","author":"Dumont","year":"2000","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0150","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0703162","article-title":"BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist","volume":"129","author":"Dumont","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2018.01.001","article-title":"Activation of NPY-Y2 receptors ameliorates disease pathology in the R6\/2 mouse and PC12 cell models of Huntington\u2019s disease","volume":"302","author":"Fatoba","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1994.tb19806.x","article-title":"Possible mechanisms for the powerful actions of neuropeptides","volume":"739","author":"Fuxe","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fneur.2014.00063","article-title":"Neuroactive peptides as putative mediators of antiepileptic ketogenic diets","volume":"5","author":"Giordano","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2019.02.002","article-title":"Are neuropeptides relevant for the mechanism of action of SSRIs?","volume":"75","author":"Go\u0142yszny","year":"2019","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0175","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/j.1460-9568.2012.08232.x","article-title":"Protective role of neuropeptide Y Y\u2082 receptors in cell death and microglial response following methamphetamine injury","volume":"36","author":"Gon\u00e7alves","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0180","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0024-3205(86)90061-5","article-title":"Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system","volume":"38","author":"Gray","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1476-5381.1994.tb17055.x","article-title":"Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro","volume":"113","author":"Greber","year":"1994","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.pnpbp.2021.110349_bb0190","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/0165-1838(90)90104-Q","article-title":"Effects of centrally administered clonidine and neuropeptide Y on arterial blood pressure in the rat after transient forebrain ischemia","volume":"30","author":"Grimaldi","year":"1990","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0195","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2018.06.006","article-title":"Intranasal administration of progesterone: a potential efficient route of delivery for cerebroprotection after acute brain injuries","volume":"145","author":"Guennoun","year":"2019","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000495130","article-title":"Involvement of neuropeptide Y in post-incisional nociception in rats","volume":"25","author":"Gupta","year":"2018","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1517\/13543784.6.4.437","article-title":"The therapeutic potential of neuropeptide Y in cardiovascular disease","volume":"6","author":"Hudspith","year":"1997","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hipo.20264","article-title":"Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor","volume":"17","author":"Ishida","year":"2007","journal-title":"Hippocampus."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0215","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1210\/er.2007-0003","article-title":"Neuropeptide Y receptor selective ligands in the treatment of obesity","volume":"28","author":"Kamiji","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0220","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1471-4159.1999.0730641.x","article-title":"Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices","volume":"73","author":"King","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hipo.450030111","article-title":"On the sites of presynaptic inhibition by neuropeptide Y in rat hippocampus in vitro","volume":"3","author":"Klapstein","year":"1993","journal-title":"Hippocampus."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00109-013-1092-3","article-title":"Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R","volume":"92","author":"Kloster","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0235","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2013.10.014","article-title":"Role of neuropeptides in anxiety, stress, and depression: from animals to humans","volume":"47","author":"Kormos","year":"2013","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.npep.2013.10.015","article-title":"Neuropeptides in epilepsy","volume":"47","author":"Kovac","year":"2013","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0245","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1432-1033.1997.t01-1-00780.x","article-title":"Solution structure of neuropeptide tyrosine 13-36, a Y2 receptor agonist, as determined by NMR","volume":"246","author":"Labelle","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0250","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nut.2008.06.025","article-title":"Molecular recognition of the NPY hormone family by their receptors","volume":"24","author":"Lindner","year":"2008","journal-title":"Nutrition."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.npep.2012.09.001","article-title":"Multifaces of neuropeptide Y in the brain--neuroprotection, neurogenesis and neuroinflammation","volume":"46","author":"Malva","year":"2012","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0260","first-page":"35","article-title":"Molecular ligand-receptor interaction of the NPY\/PP peptide family","author":"Merten","year":"2006","journal-title":"EXS."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","article-title":"XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10717544.2013.838713","article-title":"Insights into direct nose to brain delivery: current status and future perspective","volume":"21","author":"Mittal","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0275","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bmcl.2013.11.061","article-title":"Ligands of the neuropeptide Y Y2 receptor","volume":"24","author":"Mittapalli","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0285","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2011.06.030","article-title":"Role of neuropeptide Y Y1 and Y2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety","volume":"62","author":"Morales-Medina","year":"2012","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0290","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.npep.2012.09.009","article-title":"Chronic administration of the Y2 receptor antagonist, JNJ-31020028, induced anti-depressant like-behaviors in olfactory bulbectomized rat","volume":"46","author":"Morales-Medina","year":"2012","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0295","doi-asserted-by":"crossref","first-page":"896","DOI":"10.2174\/1389557514666141029233816","article-title":"Neuropeptide Y1 and Y5 receptor antagonists as potential anti-obesity drugs. Current status","volume":"14","author":"Moreno-Herrera","year":"2014","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0300","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamaneurol.2013.6299","article-title":"Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke","volume":"71","author":"Neuhaus","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1017\/S1461145705005158","article-title":"Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram","volume":"8","author":"Nikisch","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"32","key":"10.1016\/j.pnpbp.2021.110349_bb0310","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0269881118754680","article-title":"Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: therapeutic implications","volume":"2018","author":"Olloquequi","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0035-1565241","article-title":"The effects of antidepressants on neuropeptide Y in patients with depression and anxiety","volume":"49","author":"Ozsoy","year":"2016","journal-title":"Pharmacopsychiatry."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0320","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1016\/j.bmcl.2011.06.124","article-title":"Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder","volume":"21","author":"Packiarajan","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2008.05.004","article-title":"Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice","volume":"55","author":"Painsipp","year":"2008","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0330","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00125-014-3292-y","article-title":"Peptide YY: more than just an appetite regulator","volume":"57","author":"Persaud","year":"2014","journal-title":"Diabetologia."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(92)90089-R","article-title":"Feeding and drinking responses to neuropeptide Y injections in the paraventricular hypothalamic nucleus of aged rats","volume":"575","author":"Pich","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0340","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1007\/s12274-018-2030-z","article-title":"Polarization effect in tip-enhanced infrared nanospectroscopy studies of the selective Y5 receptor antagonist Lu AA33810","volume":"11","author":"Piergies","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0345","doi-asserted-by":"crossref","first-page":"17276","DOI":"10.1021\/acs.jpcc.7b04435","article-title":"Monitoring the interfacial behavior of selective Y5 receptor antagonist on colloidal gold nanoparticle surfaces: surface-enhanced vibrational spectroscopy studies","volume":"121","author":"Pi\u0119ta","year":"2017","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0350","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0140-6736(92)90347-6","article-title":"Pathophysiology of acute ischaemic stroke","volume":"339","author":"Pulsinelli","year":"1992","journal-title":"Lancet."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0355","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","article-title":"Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0360","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0365","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1523\/JNEUROSCI.4220-08.2009","article-title":"Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer\u2019s disease","volume":"29","author":"Rose","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.160","article-title":"Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate","volume":"4","author":"Santos-Carvalho","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0375","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-540-74805-2_13","article-title":"Presynaptic neuropeptide receptors","volume":"184","author":"Schlicker","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/5584_2019_427","article-title":"Physiological and therapeutic roles of neuropeptide Y on biological functions","volume":"1237","author":"Shende","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0385","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-009-1726-x","article-title":"In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor","volume":"208","author":"Shoblock","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0390","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1471-4159.2001.00560.x","article-title":"Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus","volume":"79","author":"Silva","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0395","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0028-3908(02)00382-9","article-title":"Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus","volume":"44","author":"Silva","year":"2003","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0400","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj.02-0885fje","article-title":"Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures","volume":"17","author":"Silva","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0405","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1568007054546153","article-title":"The putative neuroprotective role of neuropeptide Y in the central nervous system","volume":"4","author":"Silva","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1471-4159.2004.03005.x","article-title":"Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats","volume":"93","author":"Silva","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0415","first-page":"979","article-title":"Neuroprotective effect of NPY on kainate neurotoxicity in the hippocampus","volume":"55","author":"Smia\u0142owska","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0420","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2009.02.002","article-title":"Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo","volume":"43","author":"Smia\u0142owska","year":"2009","journal-title":"Neuropeptides."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0425","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.21046","article-title":"Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals","volume":"499","author":"Stani\u0107","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0430","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0435","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0440","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0445","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1523\/JNEUROSCI.4893-04.2005","article-title":"Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum","volume":"25","author":"Thiriet","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0450","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1460-9568.2003.02725.x","article-title":"Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors","volume":"18","author":"Tschenett","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0455","first-page":"1","article-title":"Imaging of intranasal drug delivery to the brain","volume":"10","author":"Veronesi","year":"2020","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0460","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.108.144634","article-title":"The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity","volume":"328","author":"Walker","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0465","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/psc.1357","article-title":"Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development","volume":"17","author":"Walther","year":"2011","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0470","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0006-8993(91)91621-7","article-title":"Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain","volume":"539","author":"Widdowson","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0475","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14728222.2011.628314","article-title":"Central functions of neuropeptide Y in mood and anxiety disorders","volume":"15","author":"Wu","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0480","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1745-7254.2005.00011.x","article-title":"Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity","volume":"26","author":"Wu","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pnpbp.2021.110349_bb0485","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.peptides.2006.09.031","article-title":"Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures","volume":"28","author":"Xapelli","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.pnpbp.2021.110349_bb0490","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1460-9568.2008.06172.x","article-title":"Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia","volume":"27","author":"Xapelli","year":"2008","journal-title":"Eur. J. Neurosci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584621001081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:57:20Z","timestamp":1759521440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584621001081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":98,"alternative-id":["S0278584621001081"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110349","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110349"}}